Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414

Clinical trial NCT06525168 · RECRUITING

Trial details

NCT number: NCT06525168
Sponsor: Chendu DIAO Nine Hong Pharmaceutical Factory
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2024-02-06
Primary completion: 2025-09-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.